FP09.02 Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes From EXCLAIM Extension Cohort
Year: 2021
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: M.R. García Campelo, C. Zhou, S. Ramalingam, H. Lin, T. Kim, G. Riely, T. Mekhail, D. Nguyen, E. Goodman, K. Le, M. Mehta, S. Popat, P. Janne
Institutions: Complexo Hospitalario Universitario A Coruña, Shanghai Pulmonary Hospital, Emory University, Takeda Oncology (United States), Seoul National University Hospital, Memorial Sloan Kettering Cancer Center, AdventHealth Orlando, Institute of Cancer Research, Royal Marsden Hospital, Dana-Farber Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3205390044